A shingles vaccine, Zostavax, was approved by the Food and Drug Administration in May 2006 for use in adults 60 years of age or older. According to research published in the New England Journal of Medicine, the vaccine cut the occurrence of shingles in half and reduced the severity and complications in people who were vaccinated but still developed shingles. The vaccine is available by prescription. The vaccine is given as one shot under the skin.
Last reviewed on 9/28/08
U.S. News's featured content providers were not involved in the selection of advertisers appearing on this website, and the placement of such advertisement in no way implies that these content providers endorse the products and services advertised. Disclaimer and a note about your health.